CN102949411A - Antioxidative health care product and preparation method thereof - Google Patents

Antioxidative health care product and preparation method thereof Download PDF

Info

Publication number
CN102949411A
CN102949411A CN2012104815040A CN201210481504A CN102949411A CN 102949411 A CN102949411 A CN 102949411A CN 2012104815040 A CN2012104815040 A CN 2012104815040A CN 201210481504 A CN201210481504 A CN 201210481504A CN 102949411 A CN102949411 A CN 102949411A
Authority
CN
China
Prior art keywords
parts
vitamin
health care
care product
preparation
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Pending
Application number
CN2012104815040A
Other languages
Chinese (zh)
Inventor
唐永红
钱博
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Xian Taikomed Medical Technology Co Ltd
Original Assignee
Xian Taikomed Medical Technology Co Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Xian Taikomed Medical Technology Co Ltd filed Critical Xian Taikomed Medical Technology Co Ltd
Priority to CN2012104815040A priority Critical patent/CN102949411A/en
Publication of CN102949411A publication Critical patent/CN102949411A/en
Pending legal-status Critical Current

Links

Landscapes

  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)

Abstract

The invention discloses an antioxidative health care product and a preparation method of the antioxidative health care product. The antioxidative health care product contains the following raw material medicinal components in parts by weight: 40 parts of coenzyme Q10, 20 parts of sodium selenite, 20 parts of zinc lactate, 15 parts of vitamin E, and 15 parts of vitamin C. According to the invention, the health care product is a capsule with the medicinal and edible raw materials as the components and is expected to reach the antioxidative effect. In addition, according to an antioxidative health care theory, the health care product is prepared by the coenzyme Q10, the sodium selenite, the zinc lactate, the vitamin E, and the vitamin C as the main raw materials based on a scientific and reasonable production technology. The product is definite in function, controllable in quality and safe to take. The preparation method of a medicinal composition of the invention is simple, and the preparation of the medicinal composition can be finished by conventional equipment.

Description

A kind of for oxidation-resisting health-care product and preparation method thereof
Technical field
The invention belongs to field of health care products, relate to a kind of pharmaceutical composition of health product, particularly a kind of for oxidation-resisting health-care product and preparation method thereof.
Background technology
The expection of developing drugs combination product reaches the anti-oxidation health function.This product according to anti-oxidation health mechanism, adopts scientific and reasonable production technology to process take coenzyme Q10, sodium selenite, zinc lactate, vitamin E, vitamin C as primary raw material, and this product function is clear and definite, and is quality controllable, takes safety.
Aging is the process that the function of health each several part tract fails gradually.From biologically, aging be biology As time goes on, spontaneous necessary process, it is complicated natural phenomena, shows as the decline of degeneration and the function of structure, adaptability and resistance go down.On the physiology, aging is regarded as the ontogeny that is performed until old age from germ cell beginning.From pathology, aging is stress and strain, damage and infection, immunoreation decline, nutritional disorder, the result of dysbolismus and carelessness and Drug abuse accumulation.Coenzyme Q10, sodium selenite, zinc lactate, vitamin E, vitamin C among the present invention, five kinds of composition synergism are removed free radical, and antioxidation reaches the health care of slow down aging.Take the crowd and can not produce dependency.
Summary of the invention
The purpose of this invention is to provide a kind of for oxidation-resisting health-care product and preparation method thereof, this drug regimen is a kind of take the integration of edible and medicinal herbs raw material as main health product capsule, this product is take coenzyme Q10, sodium selenite, zinc lactate, vitamin E, vitamin C as main composition, synergism, antioxidation reaches the aesthetic health care function of slow down aging.
Technical scheme of the present invention is: design a kind ofly for oxidation-resisting health-care product and preparation method thereof, it is characterized in that composition and weight proportion thereof that it contains crude drug are: 40 parts of coenzyme Q10s, 20 parts of sodium selenite, 20 parts of zinc lactate, 5 parts of vitamin e1s, 15 parts of vitamin Cs
Above-mentioned a kind of for oxidation-resisting health-care product and preparation method thereof, it may further comprise the steps:
1) by following weight ratio weighting raw materials: 40 parts of coenzyme Q10s, 20 parts of sodium selenite, 20 parts of zinc lactate, 5 parts of vitamin e1s, 15 parts of vitamin Cs;
2) with above-mentioned raw materials, cross 80 mesh sieves;
3) raw material of step 2 is packed into mix homogeneously in the mixer, for subsequent use;
4) with above-mentioned steps 3) mixture, upper capsule filling machine carries out filling, gets final product;
5) inner packing;
6) outer package, product inspection, warehouse-in.
Advantage of the present invention is: coenzyme Q10 is one of indispensable important element of human life in the prescription of the present invention, the nutrition of energy human activin cell and cellular energy has the body immunity of raising, strengthens the functions such as antioxidation, slow down aging and enhancing human activity; Selenium element in the sodium selenite is the important component part of some antioxidases (glutathion peroxidase) and selenium-P albumen in animal and human's body, play a part in vivo balance oxidation reduction atmosphere, can improve body immunity, antioxidation, slow down aging, the protection repair cell, and can improve erythrocytic oxygen carrying capacity, detoxifcation, anticancer; Zinc lactate helps the immune organ thymus development, effectively guarantees thymus development, and normal differentiation T lymphocyte promotes cellular immune function.Vitamin E can the anti-oxidation protection body cell be avoided the murder by poisoning of free radical, and suppress lipid peroxidation and form free radical, defying age, anticancer, prevent organic decline, and can adjust hormone, activation hypophysis.Ascorbic Main Function is to improve immunity, and prophylaxis of cancer, heart disease, apoplexy take care of one's teeth and gingiva etc.In addition, to adhere to taking vitamin c on time and can also make that dermal melanin is calm to be reduced, thereby reduce black speck and freckle, make whitening skin. vitamin C can also promote the metabolism of tyrosine and tryptophan in the aminoacid, prolongs the human body life-span.Each raw material all plays a role to antioxidation from different aspects.This prescription not only can be removed free radical, and antioxidation is anti-aging, and body immunity can improve in multivitamin, micro-unit, improves body other system function, and the health of human body is had certain assosting effect.
Pharmaceutical composition of the present invention is take coenzyme Q10, sodium selenite, zinc lactate, vitamin E, vitamin C as primary raw material, for a health product of easy old and feeble crowd's exploitation.This product is take coenzyme Q10, sodium selenite, zinc lactate, vitamin E, five kinds of raw materials of vitamin C as main component, and synergism is removed free radical, and antioxidation is anti-aging, reaches certain aesthetic health care function.No dependence.
The specific embodiment
The invention will be further described below in conjunction with specific embodiment, but not as limitation of the present invention.The part that is not described in detail in the present embodiment is to adopt prior art, and industry standard or known approaches.
Embodiment 1
Described pharmaceutical composition adopts following steps to make:
1) by following weight ratio weighting raw materials: 40 parts of coenzyme Q10s, 20 parts of sodium selenite, 20 parts of zinc lactate, 5 parts of vitamin e1s, 15 parts of vitamin Cs;
2) with above-mentioned raw materials, cross 80 mesh sieves;
3) raw material of step 2 is packed into mix homogeneously in the mixer, for subsequent use;
4) with above-mentioned steps 3) mixture, upper capsule filling machine carries out filling, gets final product;
5) inner packing;
6) outer package, product inspection, warehouse-in.
The embodiment of the invention 1 is used for the clinical observation of the drug regimen Capsule for Delaying senility disease of anti-oxidation function
1 data and method
1.1 physical data
Old and feeble patient 88 examples that selection is received treatment voluntarily, male's 44 examples, women's 44 examples.Age 55-70 year is divided into treatment group 1, treatment group 2, treatment group 3 at random, and matched group, every group of 22 examples; Each is organized the patient age symptom and consists of without significant difference.Has comparability (P〉0.05).
1.2 Therapeutic Method
The treatment group Primary Care is consistent, and matched group is not taken medicine.The treatment group 1 usefulness embodiment of the invention 1, three of every days twice, one time, 15 is a course for the treatment of.Treatment group 2 usefulness health preserving hall natural vitamin E soft capsules, one time 1,1 time on the one; Treatment group 3 Nutrilite VITAMIN C TABLET, every day 1 time, one time 2.
2 results
2.1 curative effect determinate standard
With reference to " the screening rules of Chinese medicine of Delaying Senility and clinical observation standard " design clinical observation log, once mainly observed the symptoms respectively at each record before and after the treatment: soreness of the waist and knees, aversion to cold and cold limbs, insomnia, nocturia frequency, inappetence, lassitude and weak, dysphoria with feverish sensation in the chest palms and soles, breathe hard, dizziness, tinnitus, night sweat, spontaneous perspiration, forgetful, dreaminess, greatly thin, the constipation in loose stool, picture of the tongue, pulse condition etc.
Senile symptom integration assessment method:
1. the symptom note said of all actives is 4 minutes;
2. the symptom of saying through inquiry, and it is significantly or continue the person of appearance, remembers 3 minutes:
Heavy or be interrupted the person of appearance when 3. light during symptom, remember 2 minutes;
4. symptom is slight, or does not occur the person once in a while, remembers 1 minute;
5. asymptomatic person is 0 minute;
6. have any one in inspection and the pulse-taking and be designated as 6 minutes.
According to " the senile symptom integrated value assessment method " stipulated in " the screening rules of Chinese medicine of Delaying Senility and clinical observation standard " standard, the summation that every routine inquiring, inspection and pulse-taking are scored is old and feeble witness integrated value, old and feeble witness integrated value evaluation before and after curative effect is judged to treat.
Produce effects: the long-pending value of average old and feeble witness before the value of old and feeble witness integration decline after the treatment 〉=2/3 treatment.
Effectively: the value of old and feeble witness integration declines is before 1/3~2/3 treats between the average old and feeble witness integrated value after the treatment.
Invalid: the value of old and feeble witness integration decline average old and feeble witness integration before 1/3 treatment after the treatment
Below the value.
2.2 therapeutic outcome
? Produce effects Effectively Invalid Effective percentage
Contrast ? ? 22 0
Treatment group 1 6 12 4 82%
Treatment group 2 5 11 6 73%
Treatment group 3 6 11 5 73%
3 discuss
Aging is the biological process that is caused by Various Complex factor interactions such as inherited genetic factors and internal and external environments, be the evolution process that occurs in according to certain rules biological organs, histiocytic morphology and function in the life cycle, show as variation and the disorder of a series of generals aobvious with increasing age, gradual, decline property.Basic Theories of Chinese Medicine is take internal organs as core, therefore the deficient theory of internal organs becomes one of theory that has the greatest impact in the old and feeble theory of doctor.Other theories such as aging is said, the stagnation of liver-QI aging is said, the weakness of the spleen and stomach aging is said, the turbid aging of qi depression to blood stasis expectorant is said of suffering from a deficiency of the kidney in addition.It is dirty that numerous theories are attributed to liver,spleen,kidney three.The general principle of traditional Chinese medical science slow down aging is exactly the prevention of diseae, does not always support first.Adopting coenzyme Q10, sodium selenite, zinc lactate, vitamin E, vitamin C is primary raw material, can remove free radical, and antioxidation is anti-aging, improves immunity of organisms, reaches certain health care.And then illustrate that embodiment 1 affiliated prescription is reliably effective in this invention.

Claims (2)

1. one kind is used for the oxidation-resisting health-care product, it is characterized in that composition and weight proportion thereof that it contains crude drug are: 40 parts of coenzyme Q10s, 20 parts of sodium selenite, 20 parts of zinc lactate, 5 parts of vitamin e1s, 15 parts of vitamin Cs.
2. a kind of preparation method for the oxidation-resisting health-care product according to claim 1, it may further comprise the steps:
1) by following weight ratio weighting raw materials: 40 parts of coenzyme Q10s, 20 parts of sodium selenite, 20 parts of zinc lactate, 5 parts of vitamin e1s, 15 parts of vitamin Cs;
2) with above-mentioned raw materials, cross 80 mesh sieves;
3) raw material of step 2 is packed into mix homogeneously in the mixer, for subsequent use;
4) with above-mentioned steps 3) mixture, upper capsule filling machine carries out filling, gets final product;
5) inner packing;
6) outer package, product inspection, warehouse-in.
CN2012104815040A 2012-11-23 2012-11-23 Antioxidative health care product and preparation method thereof Pending CN102949411A (en)

Priority Applications (1)

Application Number Priority Date Filing Date Title
CN2012104815040A CN102949411A (en) 2012-11-23 2012-11-23 Antioxidative health care product and preparation method thereof

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
CN2012104815040A CN102949411A (en) 2012-11-23 2012-11-23 Antioxidative health care product and preparation method thereof

Publications (1)

Publication Number Publication Date
CN102949411A true CN102949411A (en) 2013-03-06

Family

ID=47759170

Family Applications (1)

Application Number Title Priority Date Filing Date
CN2012104815040A Pending CN102949411A (en) 2012-11-23 2012-11-23 Antioxidative health care product and preparation method thereof

Country Status (1)

Country Link
CN (1) CN102949411A (en)

Cited By (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN104939075A (en) * 2015-05-26 2015-09-30 南昌大学 Anti-oxidation health product taking L-Se-methylselenocysteine as main raw material
CN106490604A (en) * 2016-11-14 2017-03-15 威海力元海洋生物科技有限公司 A kind of anti-oxidant Green Tea Extract health care product and preparation method thereof

Citations (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN101322711A (en) * 2008-01-09 2008-12-17 济南老来寿生物技术有限公司 Health care medicament for resisting fatigue and enhancing immunity and preparation thereof
CN101810336A (en) * 2010-04-30 2010-08-25 广东仙乐制药有限公司 Chewable soft capsules and method for preparing same
CN101897440A (en) * 2009-11-23 2010-12-01 北京东方红航天生物技术股份有限公司 Coenzyme Q10 composite soft capsule and preparation method thereof

Patent Citations (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN101322711A (en) * 2008-01-09 2008-12-17 济南老来寿生物技术有限公司 Health care medicament for resisting fatigue and enhancing immunity and preparation thereof
CN101897440A (en) * 2009-11-23 2010-12-01 北京东方红航天生物技术股份有限公司 Coenzyme Q10 composite soft capsule and preparation method thereof
CN101810336A (en) * 2010-04-30 2010-08-25 广东仙乐制药有限公司 Chewable soft capsules and method for preparing same

Cited By (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN104939075A (en) * 2015-05-26 2015-09-30 南昌大学 Anti-oxidation health product taking L-Se-methylselenocysteine as main raw material
CN106490604A (en) * 2016-11-14 2017-03-15 威海力元海洋生物科技有限公司 A kind of anti-oxidant Green Tea Extract health care product and preparation method thereof

Similar Documents

Publication Publication Date Title
CN102048224B (en) Red jujube health-care beverage capable of removing chloasma, beautifying features and improving skin, and production technology thereof
CN107467315A (en) A kind of tea for reducing hypertension and fat and preparation method thereof
WO2014079395A1 (en) Oil mixture capable of improving immunity
CN109170470A (en) A kind of solid beverage and preparation method thereof for treating diabetes
CN102972672A (en) Drug composite effervescent granule for supplementing nutrition and preparation method thereof
CN102949411A (en) Antioxidative health care product and preparation method thereof
CN104352542A (en) Sea cucumber and saussurea involucrata composition preparation and preparation method thereof
CN107373312A (en) One kind conditioning health-preserving porridge powder
CN101721403A (en) Application of fucoxanthin in aspect of losing weight
CN111000232A (en) Traditional Chinese medicine medicated diet for insomnia
CN101120750B (en) Method for preparing ginkgo bee product
CN102908396B (en) Chinese medicinal composition for promoting sleeping and preparation method thereof
CN104366349A (en) Nutritious crispy date and pine nut porridge and cooking method thereof
CN102100338A (en) Nerve-calming and sleep-assisting porridge
CN108433108A (en) Six red pigment preparations of one kind and preparation method thereof
CN107801995A (en) A kind of asparagus composition for preventing and nursing one's health menopause symptom and its application
CN101991829B (en) Medicament for treating stomach illness
KR20210097487A (en) Composition for preventing, improving or treating sleep disorders comprising fucoidan
CN1562253A (en) Health foods in use for improving symptom in climacteric period of female and fabricating method
CN102579493A (en) Pilose antler capsule and preparation method thereof
CN103495044B (en) Pure traditional Chinese medicine preparation for treating neurosis
CN113413445B (en) Composition and preparation method and application thereof
CN103451067A (en) Anti-fatigue healthcare medicinal liquor
CN107007695A (en) A kind of toxin expelling of invigorating blood circulation purifies the blood the Chinese prescription and its preparation of fat
CN103584097A (en) Preparation and functions of longevity-promoting and health-care cream

Legal Events

Date Code Title Description
C06 Publication
PB01 Publication
C10 Entry into substantive examination
SE01 Entry into force of request for substantive examination
RJ01 Rejection of invention patent application after publication

Application publication date: 20130306

RJ01 Rejection of invention patent application after publication